Form 4: Health Catalyst COO Daniel LeSueur Sells 5,209 Shares
SEC Form 4
Health Catalyst's Chief Operating Officer, Daniel LeSueur, sold 5,209 shares of common stock at a price of $7.6812 per share on October 3, 2024.
Summary
- Daniel LeSueur, the Chief Operating Officer of Health Catalyst, Inc. (HCAT), reported a transaction involving the sale of company stock.
- On October 3, 2024, LeSueur sold 5,209 shares of common stock at a price of $7.6812 per share.
- Following the transaction, LeSueur directly owns 134,899 shares of Health Catalyst common stock.
- The sale was executed under a pre-arranged trading plan adopted on March 7, 2024, in accordance with Rule 10b5-1.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction was pre-planned under Rule 10b5-1, suggesting it wasn't based on immediate company performance or outlook.
Industry Context
Insider transactions are routinely monitored by investors to gauge executive sentiment regarding the company's prospects. While not inherently negative, a large sale can sometimes be interpreted as a lack of confidence, though in this case, it's mitigated by the pre-arranged trading plan.
Stakeholder Impact
- The stock sale could have a minor impact on shareholder sentiment, but the pre-arranged nature of the sale mitigates concerns.
Key Dates
| Date | Description |
|---|---|
| March 7, 2024 | Date the reporting person adopted a written trading plan in accordance with Rule 10b5-1 |
| October 3, 2024 | Date of the stock sale transaction |
| October 8, 2024 | Date of the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.